Stakeholder characteristics: stakeholders n = 20
| Stakeholder | Number | Comments |
|---|---|---|
| Academia (A) | 3 | Sociologists (2), Pharmacoeconomist (1) |
| Public service (PS) | 5 | Politician (1), Medsafe (1), Policy analyst (1), DHB planning (1), Pharmac (1) |
| Medicine (M) | 4 | Oncologist (1), General practice (3) |
| Pharmacist (Ph) | 3 | DHB (2), Community (1) |
| Pharmaceutical industry (PI) | 2 | Manufacturing (1), Representative (1) |
| Patient Group Representative (PGR) | 2 | Long-term conditions (2) |
| Private Health Care Organisation (PHCO) | 1 | Medical doctor (1) |
| Additional attributes of stakeholders | ||
| ▸ 3 Medically qualified doctors | ▸ 1 Health professional of Māori ethnicity | |
| ▸ 1 Pharmacist | ▸ 4 Doctors’ past or current medical group representation | |
| ▸ 3 Scientists | ▸ 3 GPs’ ethnicities: Māori, Indian and Asian; past or currently practising in areas with high numbers of respective ethnicity, including Pacifica | |
| ▸ 1 Medical IT | ||
| ▸ 1 Therapeutic assessor | ||